JP Stock MarketDetailed Quotes

190A Chordia Therapeutics

Watchlist

254
-22-7.97%

20min DelayMarket Closed Nov 29 15:30 JST

17.30BMarket Cap-8164P/E (Static)

Chordia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Aug 31, 2024

(Q4)Aug 31, 2024

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(FY)Aug 31, 2022

(FY)Aug 31, 2021

Total revenue

2.5B

800M

Cost of revenue

-24.89%1.5B

515.34M

Gross profit

-398.07%-1.5B

-515.34M

503.18M

Operating expense

3.60%301.6M

107.14%105.23M

-84.09%291.12M

-1.47B

22.97%1.83B

1.49B

Selling and administrative expenses

----

9.66%188M

--171.44M

-Selling and marketing expense

----

9.66%188M

--171.44M

Research and development costs

----

25.18%1.66B

--1.32B

Total other operating income

----

119.45%14.56M

--6.64M

Operating profit

-949.48%-1.8B

-18.51%-620.57M

111.59%212.06M

-523.63M

-166.02%-1.83B

-687.76M

Net non-operating interest income (expenses)

-8.75M

Total other finance cost

--8.75M

----

Net investment income

70.59%-3.6M

133.43%2.96M

-374.53%-12.24M

-8.85M

-729.58%-2.58M

-311K

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

-142.25%-10.96M

-374.93%-22.68M

-53.24%25.95M

8.25M

-65.93%55.49M

162.86M

Income before tax

-908.25%-1.82B

-23.81%-649.04M

112.71%225.76M

-524.23M

-238.27%-1.78B

-525.21M

Income tax

0.00%2.42M

0.00%605K

0.00%2.42M

605K

27.37%2.42M

1.9M

Net income

-918.09%-1.83B

-23.78%-649.65M

112.55%223.34M

-524.84M

-237.51%-1.78B

-527.11M

Net income continuous operations

-918.09%-1.83B

-23.78%-649.65M

112.55%223.34M

---524.84M

-237.51%-1.78B

---527.11M

Noncontrolling interests

Net income attributable to the company

-918.09%-1.83B

-23.78%-649.65M

112.55%223.34M

-524.84M

-237.51%-1.78B

-527.11M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-918.09%-1.83B

-23.78%-649.65M

112.55%223.34M

-524.84M

-237.51%-1.78B

-527.11M

Gross dividend payment

Basic earnings per share

-885.61%-31.11

-10.22%-10.2489

112.56%3.96

-9.2984

-237.51%-31.5191

-9.3386

Diluted earnings per share

-885.61%-31.11

-10.22%-10.2489

112.56%3.96

-9.2984

-237.51%-31.5191

-9.3386

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Aug 31, 2024	(Q4)Aug 31, 2024	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(FY)Aug 31, 2022	(FY)Aug 31, 2021
Total revenue	0	0	2.5B	0	0	800M
Cost of revenue	-24.89%1.5B	515.34M	2B
Gross profit	-398.07%-1.5B	-515.34M	503.18M
Operating expense	3.60%301.6M	107.14%105.23M	-84.09%291.12M	-1.47B	22.97%1.83B	1.49B
Selling and administrative expenses	----	----	----	----	9.66%188M	--171.44M
-Selling and marketing expense	----	----	----	----	9.66%188M	--171.44M
Research and development costs	----	----	----	----	25.18%1.66B	--1.32B
Total other operating income	----	----	----	----	119.45%14.56M	--6.64M
Operating profit	-949.48%-1.8B	-18.51%-620.57M	111.59%212.06M	-523.63M	-166.02%-1.83B	-687.76M
Net non-operating interest income (expenses)	-8.75M		0
Total other finance cost	--8.75M	----	----	----	----	----
Net investment income	70.59%-3.6M	133.43%2.96M	-374.53%-12.24M	-8.85M	-729.58%-2.58M	-311K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)	-142.25%-10.96M	-374.93%-22.68M	-53.24%25.95M	8.25M	-65.93%55.49M	162.86M
Income before tax	-908.25%-1.82B	-23.81%-649.04M	112.71%225.76M	-524.23M	-238.27%-1.78B	-525.21M
Income tax	0.00%2.42M	0.00%605K	0.00%2.42M	605K	27.37%2.42M	1.9M
Net income	-918.09%-1.83B	-23.78%-649.65M	112.55%223.34M	-524.84M	-237.51%-1.78B	-527.11M
Net income continuous operations	-918.09%-1.83B	-23.78%-649.65M	112.55%223.34M	---524.84M	-237.51%-1.78B	---527.11M
Noncontrolling interests
Net income attributable to the company	-918.09%-1.83B	-23.78%-649.65M	112.55%223.34M	-524.84M	-237.51%-1.78B	-527.11M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0
Net income attributable to common stockholders	-918.09%-1.83B	-23.78%-649.65M	112.55%223.34M	-524.84M	-237.51%-1.78B	-527.11M
Gross dividend payment
Basic earnings per share	-885.61%-31.11	-10.22%-10.2489	112.56%3.96	-9.2984	-237.51%-31.5191	-9.3386
Diluted earnings per share	-885.61%-31.11	-10.22%-10.2489	112.56%3.96	-9.2984	-237.51%-31.5191	-9.3386
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data